Nobel Biocare profits plunge in Q2
Despite a slight uptick in sales, Nobel Biocare saw a 30.5% drop in net profit for the second quarter of 2010 (end-June 30). The Swiss dental-implant company reported net profit of 19.6 million euros ($25.2 million) for the quarter, down from 28.2 million euros ($36.3 million) for the same quarter in 2009. “After a slow first quarter, sales momentum has improved gradually in the second quarter,” said Domenico Scala, CEO,

